华测检测2025年业绩预增，海外并购整合顺利

Core Viewpoint - The company Huace Testing (300012) forecasts a net profit increase of 10%-11% for 2025, driven by successful overseas acquisitions, ongoing development in emerging businesses, and optimized corporate governance, amidst significant fluctuations in market capital flows [1][2]. Financial Performance - The company expects a net profit attributable to shareholders for 2025 to be between 1,012.77 million yuan and 1,021.49 million yuan, representing a year-on-year growth of 10%-11%. The fourth quarter is projected to see a net profit increase of 15%-20% [2]. Project Advancement - In the second half of 2025, the company completed acquisitions of SafetySA in South Africa, Emicert in Greece, and MIDAC laboratory in France, with successful integration into the company’s financials in the fourth quarter. However, the immediate contribution to earnings is limited, with long-term growth potential expected to gradually materialize [3]. Business Development - The company continues to focus on strategic areas such as semiconductor testing, low-altitude economy, and pharmaceutical testing. In semiconductor testing, it provides reliability validation services for AI computing chips, while in pharmaceutical testing, it is advancing technology reserves and qualification applications related to new viruses. These business segments are expected to increase their revenue share [4]. Corporate Structure and Governance - On December 25, 2025, the company completed a board of directors' election, with Wan Feng appointed as chairman. New committees, including a strategy and ESG committee, were established to enhance governance efficiency [5]. Capital Movements - Recent trading data indicates significant capital fluctuations, with a net outflow of 58.49 million yuan on January 20, 2026, and a further net outflow of 37.72 million yuan on January 26, 2026. These dynamics may reflect short-term market sentiment [6].